Form 3 Filing by Thomas Graney for AC Immune SA

This filing details a Form 3, an initial statement of beneficial ownership of securities, for Thomas Graney, a director at AC Immune SA (ACIU). The report indicates that Mr. Graney directly owns 12,959 common shares. Additionally, he holds a derivative security: an option to buy 19,565 common shares, with an exercise price of $2.71, an exercise date of June 10, 2027, and an expiration date of October 1, 2036. The filing also notes 8,936 common shares underlying outstanding restricted share units, which are included in the post-transaction share count. The report was signed on October 9, 2026, for the period ending October 2, 2026.